The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival

The peritoneum is a common metastatic site in gastric cancer. This systematic review provides an overview of the incidence, risk factors and survival of synchronous peritoneal metastases from gastric cancer. A systematic search was performed to identify studies wherein the incidence, risk factors an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anouk Rijken, Robin J. Lurvink, Misha D. P. Luyer, Grard A. P. Nieuwenhuijzen, Felice N. van Erning, Johanna W. van Sandick, Ignace H. J. T. de Hingh
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/941bda462f224bd38725682a2d65f267
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:941bda462f224bd38725682a2d65f267
record_format dspace
spelling oai:doaj.org-article:941bda462f224bd38725682a2d65f2672021-11-11T17:32:21ZThe Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival10.3390/jcm102148822077-0383https://doaj.org/article/941bda462f224bd38725682a2d65f2672021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4882https://doaj.org/toc/2077-0383The peritoneum is a common metastatic site in gastric cancer. This systematic review provides an overview of the incidence, risk factors and survival of synchronous peritoneal metastases from gastric cancer. A systematic search was performed to identify studies wherein the incidence, risk factors and survival of gastric cancer with peritoneal metastases were investigated. Of all 38 potentially eligible studies, 17 studies were included based on the eligibility criteria. The incidence of synchronous gastric peritoneal metastases was reviewed for population-based studies (10–21%), for observational cohort studies (2–15%) and for surgical cohort studies (13–40%). Potential risk factors for synchronous gastric peritoneal metastases were younger age, non-cardia gastric cancer, female sex, signet ring cell carcinoma, diffuse type histology or linitis plastica, T4 stage, Hispanic ethnicity and more than one metastatic location. Synchronous peritoneal metastases are commonly diagnosed in patients with gastric cancer with an incidence up to 21% in recent population-based studies. Furthermore, prognosis of patients with gastric peritoneal metastases is poor with median overall survival ranging from 2 to 9 months. The high incidence and poor prognosis require intensive research on diagnostic features and effective treatment options to improve survival.Anouk RijkenRobin J. LurvinkMisha D. P. LuyerGrard A. P. NieuwenhuijzenFelice N. van ErningJohanna W. van SandickIgnace H. J. T. de HinghMDPI AGarticleperitoneal metastasesgastric cancerincidencetreatmentsurvivalMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4882, p 4882 (2021)
institution DOAJ
collection DOAJ
language EN
topic peritoneal metastases
gastric cancer
incidence
treatment
survival
Medicine
R
spellingShingle peritoneal metastases
gastric cancer
incidence
treatment
survival
Medicine
R
Anouk Rijken
Robin J. Lurvink
Misha D. P. Luyer
Grard A. P. Nieuwenhuijzen
Felice N. van Erning
Johanna W. van Sandick
Ignace H. J. T. de Hingh
The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
description The peritoneum is a common metastatic site in gastric cancer. This systematic review provides an overview of the incidence, risk factors and survival of synchronous peritoneal metastases from gastric cancer. A systematic search was performed to identify studies wherein the incidence, risk factors and survival of gastric cancer with peritoneal metastases were investigated. Of all 38 potentially eligible studies, 17 studies were included based on the eligibility criteria. The incidence of synchronous gastric peritoneal metastases was reviewed for population-based studies (10–21%), for observational cohort studies (2–15%) and for surgical cohort studies (13–40%). Potential risk factors for synchronous gastric peritoneal metastases were younger age, non-cardia gastric cancer, female sex, signet ring cell carcinoma, diffuse type histology or linitis plastica, T4 stage, Hispanic ethnicity and more than one metastatic location. Synchronous peritoneal metastases are commonly diagnosed in patients with gastric cancer with an incidence up to 21% in recent population-based studies. Furthermore, prognosis of patients with gastric peritoneal metastases is poor with median overall survival ranging from 2 to 9 months. The high incidence and poor prognosis require intensive research on diagnostic features and effective treatment options to improve survival.
format article
author Anouk Rijken
Robin J. Lurvink
Misha D. P. Luyer
Grard A. P. Nieuwenhuijzen
Felice N. van Erning
Johanna W. van Sandick
Ignace H. J. T. de Hingh
author_facet Anouk Rijken
Robin J. Lurvink
Misha D. P. Luyer
Grard A. P. Nieuwenhuijzen
Felice N. van Erning
Johanna W. van Sandick
Ignace H. J. T. de Hingh
author_sort Anouk Rijken
title The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
title_short The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
title_full The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
title_fullStr The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
title_full_unstemmed The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
title_sort burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/941bda462f224bd38725682a2d65f267
work_keys_str_mv AT anoukrijken theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT robinjlurvink theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT mishadpluyer theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT grardapnieuwenhuijzen theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT felicenvanerning theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT johannawvansandick theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT ignacehjtdehingh theburdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT anoukrijken burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT robinjlurvink burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT mishadpluyer burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT grardapnieuwenhuijzen burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT felicenvanerning burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT johannawvansandick burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
AT ignacehjtdehingh burdenofperitonealmetastasesfromgastriccancerasystematicreviewontheincidenceriskfactorsandsurvival
_version_ 1718432076921831424